The Centre of Excellence in Severe Asthma is hosting Dr Robert Niven who presents "Clinical Trials for Severe Asthma."

CRE Seminar Series: Dr. Robert Niven "Clinical Trials Endpoints for Severe Asthma

Wednesday, 8 March 2017, 02:00 pm — Wednesday, 8 March 2017, 03:00 pm

Location Caves Lecture Theatre, Level 4, Hunter Medical Research Institute (HMRI)
RSVP Wednesday, 1 March 2017

Dr Robert Niven


The Centre of Excellence in Severe Asthma is hosting Dr Robert Niven (University of Manchester, University Hospital of South Manchester), for a webinar on Clinical Trials Endpoints for Severe Asthma. This presentation will be a public lecture and also available live and online.

Dr. Niven runs a supra-regional service for severe asthma. He has assessed over 2,000 severe asthma patients, with around 50% of these referrals being for patients on maintenance oral steroids. He is a core member of the UK National Severe Asthma Network, with nearly 1,000 patients entered onto a national database from multiple centres, with Manchester a core contributor.

He has published over 100 peer-reviewed papers and 5 book chapters. Areas of interest have included occupational lung disease, environmental epidemiology and clinical practice in severe asthma. His research has assessed hypertonic saline for bronchiectasis therapy, awareness and diagnosis of dysfunctional breathing patterns, the role of antifungal therapy in severe asthma with fungal sensitisation and trials of bronchial thermoplasty and new biologics.

Webinar and Seminar Registration

  • Register for the online webinar
  • Catering will be provided before the seminar from 1:30 PM, in the HMRI café area. If you have any questions or would like to RSVP  by the 1st March to attend in person (Caves Theatre, HMRI), please contact
  • More information is available on the CRE website and a recording of this webinar will be available after the event.  If you are interested in hearing more about our events and research, please subscribe for the email list on the CRE homepage or follow us on Twitter (@SevereAsthmaCRE).